Author name: lifesciencenet

ADC – Antibody-Drug Conjugate: An Overview

ADC or Antibody-Drug Conjugate is an innovative class of biopharmaceutical drugs that has the potential to revolutionize cancer treatment. ADC is a type of targeted therapy that combines the specificity of monoclonal antibodies (mAbs) with the potent cytotoxic effects of chemotherapy drugs. This unique combination allows for selective delivery of toxic payloads to cancer cells …

ADC – Antibody-Drug Conjugate: An Overview Read More »

Scroll to Top